William Pedranti

William Pedranti Email and Phone Number

Chief Executive Officer @ Visgenx
Ladera Ranch, CA, US
About William Pedranti

Possible summary:As the CEO of Visgenx, Mr. Pedranti is leading the development of innovative gene therapies for degenerative retinal disorders, such as age-related macular degeneration. He has over 20 years of experience in the biotech and pharmaceutical industry, spanning from R&D and clinical development to corporate strategy and business development.Prior to joining Visgenx, he co-founded and is a partner at PENG Life Science Ventures, a venture firm that supports entrepreneurs and visionaries in transforming the healthcare and life sciences sector. He has been involved in raising over $375 million in capital and negotiating transactions worth over $1 billion, including the sale of products and companies. He also co-founded and served as the president of operations at Scilex Pharmaceuticals, where he took a product from its inception to FDA approval and commercial launch. He holds a B.S. in Business Administration from USC and a J.D. from Georgetown.

William Pedranti's Current Company Details
Visgenx

Visgenx

View
Chief Executive Officer
Ladera Ranch, CA, US
Website:
visgenx.com
Employees:
7
William Pedranti Work Experience Details
  • Visgenx
    Chief Executive Officer
    Visgenx
    Ladera Ranch, Ca, Us
  • Visgenx
    Chief Executive Officer
    Visgenx May 2023 - Present
    Santa Cruz, California, Us
    Developing gene therapy for degenerative retinal disorders.
  • Peng Life Science Ventures
    Co-Founder And Partner
    Peng Life Science Ventures Apr 2019 - Present
    PENG Life Science Ventures (PENG LSV) is an independent and forward-thinking healthcare and life sciences venture firm. Our firm has started and invested in multiple companies in various therapeutic areas including oncology, ophthalmology, infectious disease, neurology and nephrology. We have taken a company from co-founding, through clinical development, product approval, commercial launch and then subsequent sale. Our goal is to support entrepreneurs and visionaries in taking their companies to the next level and transforming industries. Our founders have decades of experience in founding and leading companies through financings, transactions, transitions, development (both R&D and clinical) and commercialization. We can provide seed capital, collaborative support and advisory services in multiple, critical areas, including corporate development, strategy, logistics, clinical development, commercial readiness, manufacturing, business development and capital raises. In this regard, PENG LSV wants to be the value-driven partner that propels game-changing innovation.
  • Iacta Pharmaceuticals
    Co-Founder & Board Member
    Iacta Pharmaceuticals Jan 2017 - Present
    Irvine, California, Us
    IACTA Pharmaceuticals was established with a team of former Allergan executives to develop and commercialize innovative eyecare products. The Company is dedicated to treating diseases, advancing technology and improving patient outcomes. It currently has two Phase 2 and two pre-clinical assets in its pipeline.
  • Just C, Inc.
    Member, Board Of Directors
    Just C, Inc. Jun 2016 - Aug 2020
    Just C is the marketer of health drinks and gummies, ARYA (aryaforlife.com). ARYA is the brand for low calorie drinks and gummies with the active ingredient (Curcumin) extracted from turmeric with well-established anti-inflammatory and antioxidant properties. The newly developed form of Curcumin (patented) can be easily dissolved in water, is highly absorbable (27x more than regular Curcumin) and is tasteless which makes it ideal to be used in food and beverages.
  • Inflammatory Response Research, Inc.
    Board Member
    Inflammatory Response Research, Inc. May 2019 - Apr 2020
    Inflammatory Response Research, Inc (IRR) is a drug development company focused on pharmaceutical products for the treatment of inflammatory disorders and conditions, including the common cold, traumatic brain injury, and acute radiation syndrome.
  • Scilex Pharmaceuticals, Inc.
    Co-Founder And President, Operations
    Scilex Pharmaceuticals, Inc. Feb 2014 - Apr 2019
    Scilex Pharmaceuticals is a privately-held biotech company focused on acquiring, developing and commercializing products for the treatment of pain.Co-founded the company with the intent of finding late-stage opportunities that we could obtain FDA approval for and launch. Key accomplishments:1. In-licensed the rights to a next-generation lidocaine patch from Japanese partners2. Raised ~$20 million to support development3. Sold the company for $70 million to a larger pharmaceutical company 4. Obtained approval for ZTlido(R) (lidocaine topical system) 1.8%5. Raised $140 million to support commercialization through Morgan Stanley6. Helped build a 150 person organization to launch ZTlido (R) (lidocaine topical system) 1.8%As President, Operations, I was responsible for all matters related to Legal, Compliance, Medical Affairs, Research & Development, Supply and Logistics and Quality.
  • Hall Estill
    Shareholder
    Hall Estill Jun 2013 - Feb 2014
    Tulsa, Oklahoma, Us
    • Shareholder at a full-service business law firm with more than 125 attorneys practicing in Oklahoma, Arkansas and Washington, D.C. • Represent life science (pharmaceutical, biotech and medical device) and other industry clients in various corporate matters including M&A, SEC, healthcare compliance, FDA regulatory, financings and corporate governance
  • Snell & Wilmer
    Partner
    Snell & Wilmer Feb 2012 - Jun 2013
    Phoenix, Az, Us
    Leader in the Bioscience & Healthcare Practice Group • Partner at a full-service business law firm with more than 400 attorneys practicing throughout the southwestern United States and Mexico• Represent life science (pharmaceutical, biotech and medical device) and other industry clients in various corporate matters including M&A, SEC, healthcare compliance, FDA regulatory, financings and corporate governance• Represented a private medical marketing company in the sale of its business • Represented a private medical device company in a corporate reorganization to position itself for a future financing transaction• Represented a controlling stockholder in the acquisition of the remaining stock of a private auto parts company• Represent a controlling stockholder in the sale of his stock in a private U.S. telecommunications company and its European subsidiary• Represent several private biotech startups in corporate formation, capital finance and regulatory and clinical development strategy• Member of the Promotional Review Committee for a public pharmaceutical company tasked with reviewing and approving all promotional materials
  • Gordon & Rees Llp
    Partner
    Gordon & Rees Llp Jan 2011 - Feb 2012
    San Francisco, Ca, Us
    Co-Chair of the National Life Sciences Practice Group• Partner with a national AM LAW 155 law firm• Started the life sciences practice group to provide top notch legal services to life science companies in a cost-effective manner• Represented life science and other industry clients in various corporate matters including M&A, SEC, healthcare compliance, FDA regulatory affairs, financings, proxy contests and corporate governance• Provided FDA regulatory advice on various commercial initiatives to ensure corporate compliance with FDA regulations• Structures, drafted and negotiated contracts including commercial, operating, supply, employment, IT, indemnification, consulting and confidentiality agreements • Provided counsel and reviewed and drafted documents for investor-led takeover of the Board of Directors of a privately-held medical device company• Corporate Secretary for and attended Board of Director meetings of a privately-held medical device company• Drafted and reviewed securities offering documents for various types of offerings (equity, debt, etc.) • Provided litigation support on corporate M&A and offering matters
  • William Pedranti, Esq.
    Life Science Advisor
    William Pedranti, Esq. May 2010 - Jan 2011
    • Engaged to assist a small biotech company in establishing a commercial infrastructure to prepare for the launch of the company’s first commercial product• Provided the executive team and senior management members with both business and legal advice on issues that impact various areas of the business• Assisted with the review and drafting of the corporate compliance program, commercial compliance policies and standard operating procedures• Structured, drafted and negotiated contracts including commercial, wholesale, distribution, employment, IT, consulting and confidentiality agreements • Member of the Promotional Review Committee tasked with reviewing and approving all promotional materials• Provided legal advice regarding reimbursement issues including payment assistance programs• Reviewed SEC documents including Form 10-Q and 8-Ks• Managed outside counsel on a range of subject matters including corporate, regulatory and employment issues• Provided FDA regulatory advice on various commercial initiatives to ensure corporate compliance with FDA regulations• Provided commercial compliance training to the commercial team including sales representatives and their managers
  • Spectrum Pharmaceuticals
    Vice President, General Counsel; Member Of The Executive Committee
    Spectrum Pharmaceuticals Mar 2004 - May 2010
    Lake Forest, Illinois, Us
    Leadership• Member of the Company’s executive team that set and the Company’s strategy and annual goals and oversaw execution of the strategy and goals• During tenure, the Company launched it first two commercial products• The Company was ranked #22 Fastest Growing Company in North America on Deloitte's 2009 Technology Fast 500™• Built the legal department from the ground up; members of the legal department consistently got recognized for outstanding performance • Served as the Company’s Compliance Officer overseeing all areas of compliance for the Company• Member of the Board of Directors of OncoRx Pharma Private Limited, a subsidiary• Managed outside counsel on a range of subject matters including litigation, intellectual property, regulatory, employment and insurance issues• Established alternative fee structures with outside counsel saving the Company money• Established outside counsel review program in order to obtain better, more cost effective serviceTransactional• Lead counsel on equity financing transactions that raised over $200 million• Lead counsel on in-licensing or acquisitions of 8 drug products, including one marketed product• Lead counsel on sale and licensing agreements that generated over $65 million upfront. • Structured, drafted and negotiated merger, asset sale and purchase, license, supply, commercial, partnership, distribution, co-promotion, clinical study, material transfer, employment, IT, consulting and confidentiality agreements Corporate Governance and Compliance• Attended Board of Directors and Board Committee meetings and provided advice on various topics including corporate governance• Provided advice on regulatory issues to ensure corporate compliance with FDA regulations • Served on the Promotional Review Committee tasked with reviewing and approving all promotional materialsSEC and Other• Drafted and reviewed all public company filings• Drafted and implemented employee equity plans
  • Latham & Watkins Llp
    Attorney
    Latham & Watkins Llp Sep 2000 - Mar 2004
    Corporate• Performed general company representation, including providing day-to-day legal advice on all aspects of operation and business strategy• Formed new entities• Prepared and implemented equity-based executive compensation plans• Provided counsel regarding compliance with SEC and Nasdaq corporate governance standards including the drafting and filing of periodic securities and regulatory reports, confidential treatment requests and registrations statements• Represented acquirers and target companies in various types of mergers and acquisitions as well as companies in securities offerings which included handling all aspects of such transactions such as drafting and negotiating asset purchase agreements, merger agreements, securities purchase agreements, registration right agreements, certificates of designation, forms of indenture, warrants and legal opinionsReal Estate• Drafted documents related to the sale of real property including purchase agreements, promissory notes and deeds• Drafted limited liability company operating agreements for real estate clientsLitigation• Handled various aspects of pre-trial discovery, including preparing discovery motions, propounding and responding to discovery, and drafting legal memoranda and other pleadings• Represented indigent clients on a pro bono basis for various family law matters including obtaining temporary restraining orders, custody orders and divorce settlements• Engaged in settlement negotiations; participated in hearings in state court; and represented victims in criminal matters

William Pedranti Skills

Mergers And Acquisitions Intellectual Property Licensing Corporate Governance Corporate Law Start Ups Biotechnology Due Diligence Pharmaceutical Industry Legal Writing Legal Advice Medical Devices Legal Assistance Contract Negotiation Venture Capital Life Sciences Patents Joint Ventures Technology Transfer Fda Lifesciences Mergers Securities Regulation Acquisitions Pharmaceuticals Legal Services

William Pedranti Education Details

  • Georgetown University Law Center
    Georgetown University Law Center
    Law
  • University Of Southern California
    University Of Southern California
    Business Entrepreneurship

Frequently Asked Questions about William Pedranti

What company does William Pedranti work for?

William Pedranti works for Visgenx

What is William Pedranti's role at the current company?

William Pedranti's current role is Chief Executive Officer.

What is William Pedranti's email address?

William Pedranti's email address is wp****@****ail.com

What is William Pedranti's direct phone number?

William Pedranti's direct phone number is +194941*****

What schools did William Pedranti attend?

William Pedranti attended Georgetown University Law Center, University Of Southern California.

What are some of William Pedranti's interests?

William Pedranti has interest in Politics, Triathlons, Reading, Running, Golf, Travel, All Usc Sports.

What skills is William Pedranti known for?

William Pedranti has skills like Mergers And Acquisitions, Intellectual Property, Licensing, Corporate Governance, Corporate Law, Start Ups, Biotechnology, Due Diligence, Pharmaceutical Industry, Legal Writing, Legal Advice, Medical Devices.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.